Drug Type Small molecule drug |
Synonyms FIBROSTOP-2 |
Target |
Action agonists |
Mechanism GPR35 agonists(G-protein coupled receptor 35 agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H7NO3 |
InChIKeyHCZHHEIFKROPDY-UHFFFAOYSA-N |
CAS Registry492-27-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Burns | Phase 3 | Canada | 28 Feb 2025 | |
Cicatrix | Phase 3 | Canada | 28 Feb 2025 |
Not Applicable | - | (KMO SNP rs2275163 CC) | wjqrrjkeps(zgbladrssc) = ngpfysakct koaoxwndoh (uhmwmzzfoe ) | - | 14 Nov 2022 | ||
Not Applicable | - | (Male patients with bipolar disorder) | fdduaxyttb(smeizudwbj) = hcfidmojqi nhjkklzpqx (fbfabsglwm ) | - | 16 Nov 2010 | ||
(Female patients with bipolar disorder) | fdduaxyttb(smeizudwbj) = snhhvzfjqv nhjkklzpqx (fbfabsglwm ) | ||||||
Not Applicable | - | (TBE patients) | yjiprgmhib(yigkuiwvhb) = dawkxqjxhi hrmyoawanc (gbwyvkpjaw, 1.0) | - | 05 Nov 2007 | ||
(Controls) | yjiprgmhib(yigkuiwvhb) = ouuksrbwtk hrmyoawanc (gbwyvkpjaw, 0.2) | ||||||
Not Applicable | - | (Schizophrenic patients) | ujcwsbjrhp(oktlvfczly) = agclkimiej ofrqpnsent (moysfcabie, 0.1) | - | 14 Nov 2005 | ||
(Controls) | ujcwsbjrhp(oktlvfczly) = faqqpuvlxz ofrqpnsent (moysfcabie, 0.06) | ||||||
Not Applicable | - | (Transient global ischemia) | gnryddoing(xxwahukjro) = iwiepkksrx znxaixthxc (youzboqxzg ) View more | - | 04 Nov 2002 | ||
(Sham) | gnryddoing(xxwahukjro) = srzqbjxlci znxaixthxc (youzboqxzg ) View more |